Cognizant

Activities: Manufacturing

Trending Articles

  1. Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
  2. Therapeutic: ensifentrine for chronic obstructive pulmonary disease Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
  3. Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
  4. Bringing biotech to the Baltics: the rise of Lithuania Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
  5. Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA

Upcoming event

ISPE Singapore

28-30 August 2024 | Conference and exhibition | Singapore See all

Related Content

Digital

A “connected by intent” approach is key to harnessing the benefits of IT-OT convergence

In recent years, the biopharmaceutical market has grown at an astonishing rate. This is evidenced by a surge in mergers and acquisitions and is underpinned by the emergence of cutting-edge technologies such as gene editing and personalised medicine
Digital

Revolutionising the life science industry with generative AI

Offering more effective and affordable drug development in a highly competitive market, generative AI can be used to increase revenue opportunities, drive value and improve patient outcomes with safer products
Manufacturing

Personalised and digitised: the future of pharma

Dr Kevin Robinson recently caught up with ChargePoint’s Ben Wylie and Cognizant’s Trevor Marshall to find out what trends and innovations the pharma industry can expect in 2024
Digital

Maximising pharma’s data security with a layered defence system

The pharmaceutical landscape is changing rapidly. The demand for more affordable and effective medications is increasing and has prompted drug developers and manufacturers to adopt innovative techniques, information and operational technologies (IT/OT). Many are adopting an Industry 4.0 model, focusing on automation and data exchange to achieve operational excellence
Training & Education

Addressing the shortage of skilled staff in the pharmaceutical industry

The COVID-19 pandemic uncovered a number of weaknesses in the pharmaceutical ecosystem. Not only was the fragility of the life science industry’s supply chain exposed, the lack of availability of experienced STEM professionals to meet spiking demand was revealed as yet another vulnerability, notes Jim Lehane, Global Leader of Life Sciences Manufacturing at Cognizant
Manufacturing

Navigating the maelstrom of M&A activity: what do CDMOs do next?

In an increasingly competitive market for contract service providers, do outsourcing companies acquire, grow or take a strategically vertical or horizontal approach to service integration to live, thrive and survive? Dr Kevin Robinson recently caught up with experts from Cognizant, Samsung Biologics and Vibalogics to pose this question and find out more
Regulatory

How paperless manufacturing can support a virtual workforce environment

Jim Lehane, Operations Director at Zenith Technologies, A Cognizant Company, explains how paperless manufacturing can be adopted quickly and easily to support a virtual workforce environment and empower digital workflows
Subscribe now